Search
Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.
News
12 April 2024
Life sciences and health care companies are heavily regulated under the rigorous standards of the U.S. Food and Drug Administration to ensure high levels of quality and patient safety....
News
14 November 2023
The U.S. Federal Trade Commission (FTC) staked out its role in policing the potential competition and consumer protection implications of generative AI technologies’ use of...
News
31 October 2023
President Joe Biden signed a sweeping executive order on artificial intelligence (AI) spurring broad U.S. government action on AI safety, security, and trust and reinforcing Congressional...
Media Mention
06 July 2023
Congress isn’t moving any legislation on AI in health care yet – but lawmakers are definitely interested in the topic. New generative AI technologies are already being...
News
17 May 2023
The rapid growth of AI and its ramifications for nearly all aspects of society and the economy is placing increasing pressure on the U.S. and European governments to proactively set...
News
14 April 2023
On April 11, the U.S. Department of Health & Human Services (HHS) Office of the National Coordinator (ONC) posted a proposed rule entitled, “Health Data, Technology, and...
News
12 April 2023
On March 30, the U.S. Food and Drug Administration (FDA) published draft guidance that proposes recommendations on the types of information that should be included in a Predetermined Change ...
News
28 March 2023
While the Medicare statute provides access to healthcare services for our nation’s elderly and disabled populations, it also can serve to foreclose access for those populations when...
News
23 March 2023
The U.S. Food and Drug Administration (FDA) – in collaboration with the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) – recently...
